Inhibrx to Present INBRX-101 Data at ATS 2022 Annual Meeting
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline,...
Source: prnewswire.com
Late Breaking Mini News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Late Breaking Mini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Late Breaking Mini Today - Breaking & Trending Today